LogicBio Therapeutics, Inc. Proceeds from Issuance Initial Public Offering
LogicBio Therapeutics, Inc. reported Proceeds from Issuance Initial Public Offering of $74.86 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2020-03-16
- LogicBio Therapeutics, Inc. proceeds from issuance initial public offering for fiscal 2018 was $74.86M.
| Period end | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|
| 2018-12-31 | $74.86M 10-K · filed 2020-03-16 |